Topic

Treatment diabetes Steady

616 applications whose title mentions it. Its share of new filings over the last two years is 11% above the four years before.

Allowance rate

53%

−22 pts vs the USPTO 562 decided

Months to first action

16.0 mo

−2.6 vs the USPTO

Applications

616.0

in the record

Allowed

298.0

264 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

A61K358 apps

C07D96 apps

C07K61 apps

A61P17 apps

C12N17 apps

C12Q16 apps

Art units

165456 apps

162438 apps

162836 apps

162933 apps

164433 apps

162628 apps

Examiners

Who examines it, and how it fares with each

Kevin E Weddington27 apps

59%

Docket Central22 apps

n/a

Christina Bradley17 apps

50%

Kristina M Hellman16 apps

44%

Rei Tsang Shiao15 apps

67%

Gyan Chandra14 apps

64%

Gerald R Ewoldt13 apps

15%

Maury A Audet12 apps

42%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

Boehringer Ingelheim International GmbH23 apps

43%

Janssen Pharmaceutica NV20 apps

70%

BioKier, Inc.16 apps

27%

MERCK SHARP & DOHME CORP.16 apps

86%

SANOFI-AVENTIS DEUTSCHLAND GMBH13 apps

23%

ASTRAZENECA AB11 apps

36%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

C/O VP, IP, LEGAL25 apps

43%

MERCK18 apps

81%

DAVID A. LANE, JR.17 apps

59%

PASSE' INTELLECTUAL PROPERTY, LLC16 apps

27%

Morgan, Lewis & Bockius LLP (WA)15 apps

47%

MILLEN, WHITE, ZELANO & BRANIGAN, P.C.12 apps

83%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19881021	COMPOSITIONS COMPRISING BRINP3 VARIANTS AND METHODS OF USING THE SAME FOR TREATMENT…	2026-09-30	Pending	0	0	n/a
19623896	ANGIOTENSIN CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN II RECEPTOR ANTAGONISTS FOR…	2026-09-14	Pending	0	0	n/a
19610047	DEPOT COMPOSITION WITH CONTROLLED INITIAL BURST THROUGH HYDROPHOBIC ION PAIRING GEL…	2026-07-28	Pending	0	0	n/a
15837480	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15915560	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15655001	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15374542	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15190841	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15562319	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15352906	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in